Deals
THL Credit has formed a joint venture with Perspecta Trident, an affiliate of Perspecta Trust, to create THL Credit Logan JV.
The new joint venture is expected to invest primarily in senior secured first lien loans to middle market companies and other corporate debt investments, consistent with THL Credit's origination and underwriting strategy.
THL Credit and Perspecta have committed to initially provide USD120 million and USD30 million, respectively, of equity capital to Logan JV. In addition, Logan JV has agreed to terms with a third party to provide credit financing. Logan JV expects to begin funding the portfolio with new
Solar simulation technology specialist Eternal Sun has closed a EUR2 Million (USD2.5 Million) Series A financing from Belgian investment firm Vermec.
The investment will be used to expand international sales and service operations.
Leading research institutions, solar module manufacturers and certification authorities rely on Eternal Sun’s solar simulation systems for testing the quality of solar modules and materials.
Chokri Mousaoui, Founder and CEO of Eternal Sun, says: “In an era of continuous improvement of solar modules, our solar simulation systems are in high demand with customers that aim to accurately test the performance and reliability of their solar
Constellation, a small-cap buyout specialist with a distinctive Buy-&-Build investment strategy focused on services companies in the DACH region, has closed Constellation IV at its hard cap of EUR120 million.
Besides commitments from returning investors which included the entrepreneurs that form part of Constellation’s Industry Partner network, Constellation was pleased to have received commitments from several high quality international investors from France, Germany, Switzerland, the US and Asia. They include fund-of-funds, family offices, universities, foundations, endowments and a state pension fund.
In line with Constellation’s predecessor fund, Constellation IV follows the same investment strategy and is focused exclusively on
Arthurian Life Sciences, the fund management company led byProfessor Sir Chris Evans, has formed a partnership with US medtech firm Interrad Medical Inc.
The Minneapolis-based company is the developer and manufacturer of the unique SecurAcath®, the world’s most effective device for securing catheters in hospital patients.
The partnership is the sixth investment of The Wales Life Sciences Investment Fund, managed by Arthurian which was specifically formed to act as General Partner of the fund.
The fund has made a GBP3 million investment in Interrad Medical Inc, acting as cornerstone investor in a financing through which the company will
Maven Capital Partners (Maven) has racieved a 3.8x multiple return on its investment in control systems specialist EFC Group, via a secondary buyout to a consortium of private investor.
The exit from EFC represents the latest profitable disposal by Maven’s Aberdeen-based team. In recent years the team has overseen the sale of a number of high-growth energy services support businesses, including Nessco and Walker Technical for returns of 2.7x and 2.9x respectively.
Aberdeen-based EFC is a niche market leader providing monitoring systems and instrumentation to the oil and gas sector. Its specialist designed and engineered solutions are now used
Amit Srivastava has joined Cycle Capital Management (Cycle Capital) as Senior Partner
With more than 20 years of experience in venture capital, Srivastava brings to Cycle Capital team a very rich experience in international business development. Until recently, Srivastava served as Managing Partner and CEO of Entrepia Ventures. Prior to joining Entrepia in 2001, he worked for seven years at JP Morgan Chase, including four years at JP Morgan Partners (formerly Chase Capital Partners), where his responsibilities included leading venture capital investments in the electronics sector, oversight of private equity investments in India, and serving as the Portfolio Manager of
Mid-market private equity firm Graphite Capital has backed the management buy-out of recruitment company Human Capital Investment Group (HCIG).
HCIG is a fast growing, diversified recruitment company serving a range of specialist areas within the public and private sectors in the UK. It trades under a number of brands focused on health and social care, social housing, construction and infrastructure, and engineering. Its leading brands include Eden Brown, Caritas, Synergy, Proactive, ewi and Resourcing Group.
Graphite has acquired a majority stake in HCIG, with debt funding being provided by HSBC and RBS. The highly experienced senior management team, led
Advisory firm Clearwater International has advised Business Collaborator on its sale to private equity house YFM Equity Partners and the Management Team, led by Chairman Richard Beaton and CEO Sanjeev Shah.
Business Collaborator is at the forefront of providing Building Information Modelling (BIM) software tools, designed to ease the transition of asset construction and maintenance projects to an interactive paperless environment. The Reading-based SaaS business has over 16 years of experience and 160,000 users of its software worldwide.
The investment from YFM will see Business Collaborator exit UNIT4, a Netherlands-based global software company with operations in 26 countries worldwide,
Law firm Eversheds has advised Phoenix Equity Partners (Phoenix) on the acquisition of day nursery provider, Just Childcare Limited (Just Childcare).
The acquisition represents an initial investment alongside the founders of Just Childcare to support the future development of Just Childcare.
Just Childcare operates six day nurseries in the Northwest of England, with a seventh to open shortly. Phoenix hopes to use the acquisition of Just Childcare as a platform from which to build a leading business in this sector through bolt-on acquisitions and new openings, for which it is committing substantial additional funding.
The team was led
Creo Medical has closed a GBP3.5m funding round, led by Finance Wales, angel investors and the Angel CoFund.
The Government-backed Angel CoFund joins existing investors Finance Wales, the Arete Angel syndicate and individual business angels, including lead angel Mark Farmer, bringing the total Creo investment received to date to GBP7.9m. This is the second co-investment deal between the Angel CoFund and Finance Wales this year.
Since 2009, Creo Medical has developed innovative medical devices. This funding will be used towards the continuing development of the CROMA platform – the first new electrosurgical system in a generation – specifically with
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
